Imperial Announces Voting Results for the Election of Directors
GlobeNewswire
Today at 9:02pm UTC
Moleculin Highlights Abstract Accepted for Poster Presentation at the 2026 ASCO Annual Meeting Highlighting Cardiac Safety Data for...
GlobeNewswire
Today at 9:02pm UTC
Lynozyfic® (linvoseltamab) Monotherapy Demonstrates Deep and Rapid Responses in All Treated Patients with Second-Line-Plus Systemic Amyloid...
GlobeNewswire
Today at 9:01pm UTC
Syndax Announces Four Revuforj® (revumenib) Abstracts Accepted for ASCO 2026, Including an Oral Presentation of Post-Transplant Data
GlobeNewswire
Today at 9:01pm UTC
ALDX DEADLINE: ROSEN, A LEADING LAW FIRM, Encourages Aldeyra Therapeutics, Inc. Investors with Losses in Excess of $100K to Secure Counsel...
GlobeNewswire
Today at 9:01pm UTC
Akari Therapeutics Reports Breakthrough Preclinical Data Demonstrating Synergistic Activity of AKTX-101 with KRAS Inhibition in KRAS-Mutated...
GlobeNewswire
Today at 9:01pm UTC
AerSale Announces Participation at the 2026 Jefferies Aftermarket MRO Virtual Summit
GlobeNewswire
Today at 9:00pm UTC
Lunit Highlights AI-Powered IHC and Tumor Microenvironment Research at ASCO 2026
PR Newswire
Today at 9:00pm UTC
Legend Biotech Announces Presentations at ASCO 2026
GlobeNewswire
Today at 9:00pm UTC
Servier Presentations at ASCO 2026 Spotlight Expanding Rare Oncology Portfolio
PR Newswire
Today at 9:00pm UTC
Navient declares second quarter common stock dividend
GlobeNewswire
Today at 9:00pm UTC
Sapience Therapeutics Provides Positive Data Update from Phase 2 Trial of Lucicebtide Plus SOC in Patients with Glioblastoma at the 2026...
PR Newswire
Today at 9:00pm UTC
Cardiff Oncology Announces Webcast to Discuss Updated Phase 2 CRDF-004 Data for Onvansertib in First-Line RAS-Mutated mCRC
GlobeNewswire
Today at 9:00pm UTC
Greenberg Traurig Bolsters Government Contracts and Space Practices with Shaun Kennedy in Denver
PR Newswire
Today at 9:00pm UTC
Olema Oncology Announces Encouraging Initial Clinical Data from the Phase 1 Study of OP-3136, a KAT6 Inhibitor, at 2026 ASCO Annual Meeting
GlobeNewswire
Today at 9:00pm UTC
Boehringer Ingelheim's oncology portfolio shows strong promise across multiple cancers at ASCO 2026
PR Newswire
Today at 9:00pm UTC
NVIDIA Announces Upcoming Events for Financial Community
GlobeNewswire
Today at 9:00pm UTC
Accent Therapeutics to Present Trial in Progress Poster for Phase 1/2 Study of ATX-295 at the 2026 American Society of Clinical Oncology...
PR Newswire
Today at 9:00pm UTC
Compass Therapeutics to Present Promising Phase 1 Clinical Data for CTX-8371 in Patients with Advanced Malignancies Treated in the Post...
GlobeNewswire
Today at 9:00pm UTC
New Clinical Data for Izalontamab Brengitecan and Novel ADC Pipeline to be Presented at ASCO 2026
PR Newswire
Today at 9:00pm UTC